These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2575223

  • 1. Structure-activity relationships of MDMA-like substances.
    Nichols DE, Oberlender R.
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract] [Full Text] [Related]

  • 2. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    McKenna DJ, Peroutka SJ.
    J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
    [No Abstract] [Full Text] [Related]

  • 3. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C, Bravo G, Walsh R.
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract] [Full Text] [Related]

  • 4. ["Ecstasy" and "ice": the return of the amphetamines].
    Kaminer Y, Zemishlany Z.
    Harefuah; 1991 Jun 16; 120(12):727-9. PubMed ID: 1683637
    [No Abstract] [Full Text] [Related]

  • 5. Psychostimulant properties of MDMA.
    Gold LH, Geyer MA, Koob GF.
    NIDA Res Monogr; 1989 Jun 16; 95():345-6. PubMed ID: 2577038
    [No Abstract] [Full Text] [Related]

  • 6. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M.
    Essays Biochem; 1991 Jun 16; 26():77-87. PubMed ID: 1685707
    [No Abstract] [Full Text] [Related]

  • 7. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR, McKenna DJ, Peroutka SJ.
    Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.
    Ketabi-Kiyanvash N, Weiss J, Haefeli WE, Mikus G.
    Addict Biol; 2003 Dec 25; 8(4):413-8. PubMed ID: 14690877
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ, Kehne JH.
    Ann N Y Acad Sci; 1990 Dec 25; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract] [Full Text] [Related]

  • 10. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM, Hatoum HT, Waters IW.
    Alcohol Drug Res; 1987 Dec 25; 7(3):123-34. PubMed ID: 2881551
    [Abstract] [Full Text] [Related]

  • 11. Responses to i.v. L-tryptophan in MDMA users.
    Price LH, Ricaurte GA, Krystal JH, Heninger GR.
    NIDA Res Monogr; 1989 Dec 25; 95():421-2. PubMed ID: 2577044
    [No Abstract] [Full Text] [Related]

  • 12. 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
    Hegadoren KM, Baker GB, Bourin M.
    Neurosci Biobehav Rev; 1999 Mar 25; 23(4):539-53. PubMed ID: 10073892
    [Abstract] [Full Text] [Related]

  • 13. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine.
    Zaczek R, Hurt S, Culp S, De Souza EB.
    NIDA Res Monogr; 1989 Mar 25; 94():223-39. PubMed ID: 2575226
    [Abstract] [Full Text] [Related]

  • 14. Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.
    Schmidt CJ.
    NIDA Res Monogr; 1989 Mar 25; 94():179-95. PubMed ID: 2575224
    [No Abstract] [Full Text] [Related]

  • 15. Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.
    Ricaurte GA.
    NIDA Res Monogr; 1989 Mar 25; 94():306-22. PubMed ID: 2575227
    [Abstract] [Full Text] [Related]

  • 16. Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    McCann UD, Ricaurte GA.
    J Clin Psychopharmacol; 1993 Jun 25; 13(3):214-7. PubMed ID: 8102623
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA, Hata N, Cabrera T, Hamilton ME.
    NIDA Res Monogr; 1989 Jun 25; 95():347. PubMed ID: 2577039
    [No Abstract] [Full Text] [Related]

  • 18. Treating MDMA ('Ecstasy') toxicity.
    Padkin A.
    Anaesthesia; 1994 Mar 25; 49(3):259. PubMed ID: 7908506
    [No Abstract] [Full Text] [Related]

  • 19. [MDMA ("ecstasy"): a currently used drug in Spain].
    Prat A, Montero M, Reig R, Sanz P.
    Rev Clin Esp; 1991 Feb 25; 188(2):106-8. PubMed ID: 1675014
    [No Abstract] [Full Text] [Related]

  • 20. Neurochemistry and neurotoxicity of substituted amphetamines.
    Wagner J, Peroutka SJ.
    Neuropsychopharmacology; 1990 Jun 25; 3(3):219-20. PubMed ID: 1973040
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.